BRIEF published on 09/18/2024 at 07:05, 1 year 7 months ago Relief Therapeutics achève la phase clinique de l'étude RLF-OD032 Étude Clinique RLF-OD032 Biodisponibilité Phénylcétonurie Dichlorhydrate De Saproptérine
BRIEF published on 09/18/2024 at 07:05, 1 year 7 months ago Relief Therapeutics Completes Clinical Phase of RLF-OD032 Study Clinical Study Bioavailability RLF-OD032 Phenylketonuria Sapropterin Dihydrochloride
PRESS RELEASE published on 09/18/2024 at 07:00, 1 year 7 months ago Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 Relief Therapeutics completes clinical phase in RLF-OD032 proof-of-concept study for PKU treatment, expecting topline results in October 2024 Relief Therapeutics RLF-OD032 Proof-of-Concept Study PKU Treatment Topline Results
BRIEF published on 09/02/2024 at 07:05, 1 year 8 months ago Relief Therapeutics annonce la présentation des résultats de l'étude PKU GOLIKE au SSIEM 2024 Essai Clinique PKU GOLIKE THÉRAPEUTIQUE DE SECOURS SSIEM 2024 Phénylcétonurie
BRIEF published on 09/02/2024 at 07:05, 1 year 8 months ago Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 Clinical Trial Relief Therapeutics PKU GOLIKE SSIEM 2024 Phenylketonuria
PRESS RELEASE published on 09/02/2024 at 07:00, 1 year 8 months ago Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 Relief Therapeutics announces interim results of PKU GOLIKE study at SSIEM 2024, showing potential benefits for phenylketonuria patients. Study evaluates overnight Phe fluctuations Clinical Trial Relief Therapeutics PKU GOLIKE SSIEM 2024 Phenylketonuria
BRIEF published on 08/30/2024 at 07:05, 1 year 8 months ago Relief Therapeutics publie ses résultats financiers du premier semestre 2024 et une mise à jour de l'entreprise Résultats Financiers Essais Cliniques Mise À Jour De L'entreprise Augmentation Des Revenus Réserves De Trésorerie
BRIEF published on 08/30/2024 at 07:05, 1 year 8 months ago Relief Therapeutics Reports Half-Year 2024 Financial Results and Corporate Update Financial Results Revenue Increase Clinical Trials Corporate Update Cash Reserves
PRESS RELEASE published on 08/30/2024 at 07:00, 1 year 8 months ago Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports half-year 2024 financial results and provides corporate update, showcasing operational progress, key development programs, and financial stability Half-year Results Relief Therapeutics Financial Update Development Programs Cash Reserves
BRIEF published on 08/05/2024 at 07:05, 1 year 9 months ago Relief Therapeutics Secures Up to $11 Million from Royalty Sales FDA Approval Clinical Development Relief Therapeutics Non-dilutive Funding Royalty Sales
Published on 05/12/2026 at 04:20, 57 minutes ago AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Published on 05/12/2026 at 03:05, 2 hours 12 minutes ago UraniumX Reports Tragic Incident at Its Zoo Bay Property
Published on 05/12/2026 at 00:00, 5 hours 17 minutes ago PPX Mining Provides Update on Start-up of the Process Plant
Published on 05/12/2026 at 00:00, 5 hours 17 minutes ago Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event
Published on 05/11/2026 at 23:00, 6 hours 17 minutes ago Revolve to Present at the 16th Annual LD Micro Invitational on May 18, 2026
Published on 05/12/2026 at 01:10, 4 hours 7 minutes ago Monport Brings Advanced Laser Machine With The New Mega S and UV Laser Technology in Germany
Published on 05/12/2026 at 00:19, 4 hours 58 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA adjusts its forecast for 2026 and complies with the obligation to report losses pursuant to Section 92 of Stock Corporation Act (AktG) – Draft restructuring report submitted
Published on 05/11/2026 at 22:05, 7 hours 12 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 7 hours 12 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 8 hours 1 minute ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 19:02, 10 hours 15 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 10 hours 59 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 10 hours 59 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 11 hours 3 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 11 hours 3 minutes ago Number of shares and voting rights - April 2026 (In French only)
